Search

everythinglearnresearchcommunity

for

Search:↓

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Acer1 is essential for skin health and affects hair growth and skin cancer risk.

Cronkhite-Canada syndrome can sometimes show unusual colonic adenomatous polyps.

Citrulline in certain skin tumors suggests they mimic hair growth, helping distinguish them from other cancer types.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.

Keratoacanthomas and squamous cell carcinomas have similar keratin patterns, making them hard to tell apart.

Lung cancer biology differs between women and men, with women responding better to certain treatments.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Pancreatic cancer had a very low survival rate and was hard to treat effectively.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Nicotine from smoking may worsen hidradenitis suppurativa by affecting immune function and promoting inflammation.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Finasteride may help prevent prostate cancer.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Targeting the AhR pathway may help treat alopecia areata.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

The inhibitor affects androgen metabolism but not ovarian function.

Targeting NETs may help reduce fibrosis in Crohn's disease.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Over a third of women thought to have non-classical congenital adrenal hyperplasia didn't have it confirmed by genetic tests.

Mitotane changes steroid breakdown, affecting cortisol availability.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.